Lloyd Johnson
HAEMONETICSAbout Lloyd E. Johnson
Independent director of Haemonetics (director since 2021), age 71, and former Global Managing Director, Finance and Internal Audit at Accenture (2004–2015). He is a CPA and holds NACD Directorship Certification, with 35+ years of corporate finance, audit, risk, M&A, and governance leadership across multi-nationals; the Board has designated him an “audit committee financial expert.” Committees: Audit; Governance & Compliance; independence affirmed by the Board. Other current public boards include Apogee Enterprises, Beazer Homes USA, and VSE Corporation.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Accenture | Global Managing Director, Finance and Internal Audit | 2004–2015 | Led global internal audit; finance, risk, compliance and governance leadership |
| Delphi Automotive PLC | Executive Director, M&A and General Auditor | Prior to 2004 (pre‑Accenture) | Corporate audit; M&A leadership |
| Emerson Electric; Sara Lee; Shaw Food Services | Senior financial leadership roles | Not disclosed | Corporate finance leadership |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Apogee Enterprises, Inc. | Director | Current | Public company board |
| Beazer Homes USA, Inc. | Director | Current | Public company board |
| VSE Corporation | Director | Current | Public company board |
| AARP | Board Chair | Current | Non‑profit governance role |
| Univ. of South Carolina Business Partnership Foundation | Trustee | Current | Non‑profit/academic board |
Board Governance
- Independence and leadership: Independent director; Haemonetics maintains an independent Board Chair (Ellen M. Zane) and eight independent directors out of nine. Executive sessions of independent directors held at each regular quarterly meeting.
- Committee assignments: Audit; Governance & Compliance. The Board identified Johnson as an “audit committee financial expert.”
- Attendance and engagement: In fiscal 2025, each director attended at least 75% of Board and committee meetings; Board (7), Audit (9), Governance & Compliance (4), Technology (4), Compensation (5).
- Nomination/refreshment: Governance & Compliance Committee oversees director skills, nominations, and annual peer reviews; board service limits enforced.
Fixed Compensation
| Fiscal Year | Fees Earned ($) | Equity Grant (RSUs #) | Equity Fair Value ($) | Vesting |
|---|---|---|---|---|
| 2025 (FY ended Mar 29, 2025) | 83,000 | 2,207 | 199,954 | RSUs vest on 1st anniversary of grant |
| 2024 (FY ended Mar 30, 2024) | 83,750 | 2,226 | 199,984 | RSUs vest on 1st anniversary of grant |
- Director pay structure (non‑employee): $55,000 annual retainer + $10,000 meeting retainer (covers up to eight Board meetings); additional per‑meeting fees above that; committee member annual fees (Audit $12,000; Compensation $9,000; Governance & Compliance and Technology $6,000); Chair retainers (Audit $20,000; Compensation $15,000; Governance & Compliance and Technology $10,000); Board Chair $250,000 retainer. No perquisites or retirement benefits for directors.
Performance Compensation
| Element | Details |
|---|---|
| Performance‑linked components | None for non‑employee directors; equity is time‑based RSUs vesting after one year. |
| Clawback applicability | Company clawbacks primarily address executive awards; director compensation is time‑based RSUs and cash retainers. |
Other Directorships & Interlocks
| Company | Sector | Potential Interlock Notes |
|---|---|---|
| Apogee Enterprises, Inc. | Building products | No related‑party transactions disclosed by Haemonetics. |
| Beazer Homes USA, Inc. | Homebuilding | No related‑party transactions disclosed by Haemonetics. |
| VSE Corporation | Aftermarket/Services | No related‑party transactions disclosed by Haemonetics. |
- Board service limits: Haemonetics policy limits board and audit committee service; company affirms compliance for all directors.
Expertise & Qualifications
- CPA; NACD Directorship Certification; recognized as a “Most Influential Black Corporate Director” (Savoy 2024).
- Deep expertise in accounting and financial management, M&A, international operations, corporate governance, and enterprise risk management.
- Audit Committee Financial Expert designation at Haemonetics.
Equity Ownership
| Holder | Total Beneficial Ownership (shares) | % of Class | RSUs Unvested (#) | Notes |
|---|---|---|---|---|
| Lloyd E. Johnson | 10,240 | <1% | 2,207 (as of Mar 29, 2025) | Ownership guidelines: non‑employee directors must hold 5× annual retainer; Board reports directors are compliant. Hedging/pledging prohibited by policy. |
Insider Trades
| Date | Filing | Transaction details | Source |
|---|---|---|---|
| 2025‑07‑25 | Form 4 (Director) | Form 4 filed by Lloyd E. Johnson (details in filing) |
Governance Assessment
- Strengths
- Independence, committee expertise, and financial literacy: Independent director; member of Audit and Governance & Compliance; designated Audit Committee Financial Expert.
- Attendance and oversight rigor: Directors met at least 75% attendance; robust committee cadence (Audit 9 meetings; executive sessions each regular quarterly meeting).
- Pay and alignment: Director pay balanced between modest cash and time‑vested equity; ownership guidelines for directors (5× retainer) reported compliant; no perqs or director retirement benefits.
- Shareholder support signal: Strong say‑on‑pay approvals historically; in 2024 For 46,230,466; Against 1,460,004; Abstain 142,227; in 2025 For 43,016,961; Against 585,626; Abstain 252,730.
- Conflicts: No Item 404 related‑party transactions to report.
- Risk controls: Prohibition on hedging/pledging; robust clawback policies (executive‑focused).
- Watch items
- Multiple external public boards (Apogee, Beazer Homes, VSE) increase time commitments; company states directors comply with service limits and nomination committee reviews capacity annually.
- Beneficial ownership is relatively small (<1%); mitigated by stock ownership policy compliance and annual RSU grants.
Appendix: Key Board and Voting Data
- Board/committee meetings in FY2025: Board 7; Audit 9; Compensation 5; Governance & Compliance 4; Technology 4. Attendance ≥75% for each director.
- 2025 director election results (selected): Lloyd E. Johnson — For 43,151,041; Withhold 704,276; Broker non‑votes 1,757,724.
- Current HAE committee membership (selected): Audit (Dockendorff—Chair; Coyle; Johnson); Governance & Compliance (Zane—Chair; Abernathy; Dockendorff; Johnson).